APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Calming Pheromone

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pet Calming Pheromone Market Outlook and Growth Opportunities 2026

3 July 2026196 pages

Choose your research edition.

Industry ResearchPet Calming Pheromone Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Calming Pheromone Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Pet Calming Pheromone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Calming Pheromone Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Calming Pheromone Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Pet Calming Pheromone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pet Calming Pheromone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Calming Pheromone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Calming Pheromone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pet Calming Pheromone market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pet Calming Pheromone market include FELIWAY (Ceva), ADAPTIL (Ceva), Comfort Zone (Central Garden & Pet), Sentry (PetIQ), ThunderWorks (Ceva), Nature's Miracle (Spectrum Brands), ZENIDOG (Virbac), Beaphar and Cature, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pet Calming Pheromone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Calming Pheromone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Calming Pheromone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet Calming Pheromone market size, projected growth trends, production technologies, key applications, and end-use industries.

Pet Calming Pheromone Segment by Company

FELIWAY (Ceva)

ADAPTIL (Ceva)

Comfort Zone (Central Garden & Pet)

Sentry (PetIQ)

ThunderWorks (Ceva)

Nature's Miracle (Spectrum Brands)

ZENIDOG (Virbac)

Beaphar

Cature

Pet Calming Pheromone Segment by Type

Spray

Diffuser

Collar

Others

Pet Calming Pheromone Segment by Application

Dog

Cat

Others

Pet Calming Pheromone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pet Calming Pheromone status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pet Calming Pheromone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pet Calming Pheromone significant trends, drivers, influence factors in global and regions.

6. To analyze Pet Calming Pheromone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Calming Pheromone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Calming Pheromone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Calming Pheromone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pet Calming Pheromone market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pet Calming Pheromone industry.

Chapter 3: Detailed analysis of Pet Calming Pheromone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pet Calming Pheromone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pet Calming Pheromone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pet Calming Pheromone Industry Trends Table 2. Pet Calming Pheromone Industry Drivers Table 3. Pet Calming Pheromone Industry Opportunities and Challenges Table 4. Pet Calming Pheromone Industry Restraints Table 5. Global Pet Calming Pheromone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pet Calming Pheromone Revenue Share by Company (2021-2026) Table 7. Global Pet Calming Pheromone Sales Volume by Company (k units) & (2021-2026) Table 8. Global Pet Calming Pheromone Sales Volume Share by Company (2021-2026) Table 9. Global Pet Calming Pheromone Average Price (USD/unit) of Company (2021-2026) Table 10. Global Pet Calming Pheromone Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pet Calming Pheromone Key Company Manufacturing Base & Headquarters Table 12. Global Pet Calming Pheromone Company, Product Type & Application Table 13. Global Pet Calming Pheromone Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pet Calming Pheromone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Spray Table 18. Significant Companies of Diffuser Table 19. Significant Companies of Collar Table 20. Significant Companies of Others Table 21. Global Pet Calming Pheromone Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Pet Calming Pheromone Sales Volume by Type (2021-2026) & (k units) Table 23. Global Pet Calming Pheromone Sales Volume by Type (2027-2032) & (k units) Table 24. Global Pet Calming Pheromone Sales Volume Share by Type (2021-2026) Table 25. Global Pet Calming Pheromone Sales Volume Share by Type (2027-2032) Table 26. Global Pet Calming Pheromone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pet Calming Pheromone Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Pet Calming Pheromone Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Pet Calming Pheromone Sales Value Share by Type (2021-2026) Table 30. Global Pet Calming Pheromone Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Dog Table 32. Significant Companies of Cat Table 33. Significant Companies of Others Table 34. Global Pet Calming Pheromone Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Pet Calming Pheromone Sales Volume by Application (2021-2026) & (k units) Table 36. Global Pet Calming Pheromone Sales Volume by Application (2027-2032) & (k units) Table 37. Global Pet Calming Pheromone Sales Volume Share by Application (2021-2026) Table 38. Global Pet Calming Pheromone Sales Volume Share by Application (2027-2032) Table 39. Global Pet Calming Pheromone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Pet Calming Pheromone Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Pet Calming Pheromone Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Pet Calming Pheromone Sales Value Share by Application (2021-2026) Table 43. Global Pet Calming Pheromone Sales Value Share by Application (2027-2032) Table 44. Global Pet Calming Pheromone Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Pet Calming Pheromone Sales by Region (2021-2026) & (k units) Table 46. Global Pet Calming Pheromone Sales Market Share by Region (2021-2026) Table 47. Global Pet Calming Pheromone Sales by Region (2027-2032) & (k units) Table 48. Global Pet Calming Pheromone Sales Market Share by Region (2027-2032) Table 49. Global Pet Calming Pheromone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Pet Calming Pheromone Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Pet Calming Pheromone Sales Value Share by Region (2021-2026) Table 52. Global Pet Calming Pheromone Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Pet Calming Pheromone Sales Value Share by Region (2027-2032) Table 54. Global Pet Calming Pheromone Market Average Price (USD/unit) by Region (2021-2026) Table 55. Global Pet Calming Pheromone Market Average Price (USD/unit) by Region (2027-2032) Table 56. Global Pet Calming Pheromone Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Pet Calming Pheromone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Pet Calming Pheromone Sales by Country (2021-2026) & (k units) Table 59. Global Pet Calming Pheromone Sales Market Share by Country (2021-2026) Table 60. Global Pet Calming Pheromone Sales by Country (2027-2032) & (k units) Table 61. Global Pet Calming Pheromone Sales Market Share by Country (2027-2032) Table 62. Global Pet Calming Pheromone Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Pet Calming Pheromone Sales Value Market Share by Country (2021-2026) Table 64. Global Pet Calming Pheromone Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Pet Calming Pheromone Sales Value Market Share by Country (2027-2032) Table 66. FELIWAY (Ceva) Company Information Table 67. FELIWAY (Ceva) Business Overview Table 68. FELIWAY (Ceva) Pet Calming Pheromone Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 69. FELIWAY (Ceva) Pet Calming Pheromone Product Portfolio Table 70. FELIWAY (Ceva) Recent Development Table 71. ADAPTIL (Ceva) Company Information Table 72. ADAPTIL (Ceva) Business Overview Table 73. ADAPTIL (Ceva) Pet Calming Pheromone Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. ADAPTIL (Ceva) Pet Calming Pheromone Product Portfolio Table 75. ADAPTIL (Ceva) Recent Development Table 76. Comfort Zone (Central Garden & Pet) Company Information Table 77. Comfort Zone (Central Garden & Pet) Business Overview Table 78. Comfort Zone (Central Garden & Pet) Pet Calming Pheromone Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Comfort Zone (Central Garden & Pet) Pet Calming Pheromone Product Portfolio Table 80. Comfort Zone (Central Garden & Pet) Recent Development Table 81. Sentry (PetIQ) Company Information Table 82. Sentry (PetIQ) Business Overview Table 83. Sentry (PetIQ) Pet Calming Pheromone Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Sentry (PetIQ) Pet Calming Pheromone Product Portfolio Table 85. Sentry (PetIQ) Recent Development Table 86. ThunderWorks (Ceva) Company Information Table 87. ThunderWorks (Ceva) Business Overview Table 88. ThunderWorks (Ceva) Pet Calming Pheromone Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. ThunderWorks (Ceva) Pet Calming Pheromone Product Portfolio Table 90. ThunderWorks (Ceva) Recent Development Table 91. Nature's Miracle (Spectrum Brands) Company Information Table 92. Nature's Miracle (Spectrum Brands) Business Overview Table 93. Nature's Miracle (Spectrum Brands) Pet Calming Pheromone Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Nature's Miracle (Spectrum Brands) Pet Calming Pheromone Product Portfolio Table 95. Nature's Miracle (Spectrum Brands) Recent Development Table 96. ZENIDOG (Virbac) Company Information Table 97. ZENIDOG (Virbac) Business Overview Table 98. ZENIDOG (Virbac) Pet Calming Pheromone Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. ZENIDOG (Virbac) Pet Calming Pheromone Product Portfolio Table 100. ZENIDOG (Virbac) Recent Development Table 101. Beaphar Company Information Table 102. Beaphar Business Overview Table 103. Beaphar Pet Calming Pheromone Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Beaphar Pet Calming Pheromone Product Portfolio Table 105. Beaphar Recent Development Table 106. Cature Company Information Table 107. Cature Business Overview Table 108. Cature Pet Calming Pheromone Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Cature Pet Calming Pheromone Product Portfolio Table 110. Cature Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Pet Calming Pheromone Distributors List Table 114. Pet Calming Pheromone Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Pet Calming Pheromone Product Image Figure 2. Global Pet Calming Pheromone Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Calming Pheromone Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pet Calming Pheromone Sales (2021-2032) & (k units) Figure 5. Global Pet Calming Pheromone Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Pet Calming Pheromone Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Spray Image Figure 10. Diffuser Image Figure 11. Collar Image Figure 12. Others Image Figure 13. Global Pet Calming Pheromone Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Pet Calming Pheromone Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Pet Calming Pheromone Sales Volume Share by Type (2021-2032) Figure 16. Global Pet Calming Pheromone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pet Calming Pheromone Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pet Calming Pheromone Sales Value Share by Type (2021-2032) Figure 19. Dog Image Figure 20. Cat Image Figure 21. Others Image Figure 22. Global Pet Calming Pheromone Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Pet Calming Pheromone Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Pet Calming Pheromone Sales Volume Share by Application (2021-2032) Figure 25. Global Pet Calming Pheromone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Pet Calming Pheromone Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Pet Calming Pheromone Sales Value Share by Application (2021-2032) Figure 28. Global Pet Calming Pheromone Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Pet Calming Pheromone Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Pet Calming Pheromone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Pet Calming Pheromone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Pet Calming Pheromone Sales Value (2021-2032) & (US$ Million) Figure 33. North America Pet Calming Pheromone Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Pet Calming Pheromone Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Pet Calming Pheromone Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Pet Calming Pheromone Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Pet Calming Pheromone Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Pet Calming Pheromone Sales Value (2021-2032) & (US$ Million) Figure 39. South America Pet Calming Pheromone Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Pet Calming Pheromone Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Pet Calming Pheromone Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Pet Calming Pheromone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Pet Calming Pheromone Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Pet Calming Pheromone Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Spray
  • Diffuser
  • Collar
  • Others
Applications
  • Dog
  • Cat
  • Others
Companies covered
  • FELIWAY (Ceva)
  • ADAPTIL (Ceva)
  • Comfort Zone (Central Garden & Pet)
  • Sentry (PetIQ)
  • ThunderWorks (Ceva)
  • Nature's Miracle (Spectrum Brands)
  • ZENIDOG (Virbac)
  • Beaphar
  • Cature

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pet Calming Pheromone Sales Value (2021-2032)
  4. 1.2.2 Global Pet Calming Pheromone Sales Volume (2021-2032)
  5. 1.2.3 Global Pet Calming Pheromone Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pet Calming Pheromone Market Dynamics
  1. 2.1 Pet Calming Pheromone Industry Trends
  2. 2.2 Pet Calming Pheromone Industry Drivers
  3. 2.3 Pet Calming Pheromone Industry Opportunities and Challenges
  4. 2.4 Pet Calming Pheromone Industry Restraints
3 Pet Calming Pheromone Market by Company
  1. 3.1 Global Pet Calming Pheromone Company Revenue Ranking in 2025
  2. 3.2 Global Pet Calming Pheromone Revenue by Company (2021-2026)
  3. 3.3 Global Pet Calming Pheromone Sales Volume by Company (2021-2026)
  4. 3.4 Global Pet Calming Pheromone Average Price by Company (2021-2026)
  5. 3.5 Global Pet Calming Pheromone Company Ranking (2024-2026)
  6. 3.6 Global Pet Calming Pheromone Company Manufacturing Base and Headquarters
  7. 3.7 Global Pet Calming Pheromone Company Product Type and Application
  8. 3.8 Global Pet Calming Pheromone Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pet Calming Pheromone Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pet Calming Pheromone Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pet Calming Pheromone Market by Type
  1. 4.1 Pet Calming Pheromone Type Introduction
  2. 4.1.1 Spray
  3. 4.1.2 Diffuser
  4. 4.1.3 Collar
  5. 4.1.4 Others
  6. 4.2 Global Pet Calming Pheromone Sales Volume by Type
  7. 4.2.1 Global Pet Calming Pheromone Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pet Calming Pheromone Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Pet Calming Pheromone Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Pet Calming Pheromone Sales Value by Type
  11. 4.3.1 Global Pet Calming Pheromone Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Pet Calming Pheromone Sales Value by Type (2021-2032)
  13. 4.3.3 Global Pet Calming Pheromone Sales Value Share by Type (2021-2032)
5 Pet Calming Pheromone Market by Application
  1. 5.1 Pet Calming Pheromone Application Introduction
  2. 5.1.1 Dog
  3. 5.1.2 Cat
  4. 5.1.3 Others
  5. 5.2 Global Pet Calming Pheromone Sales Volume by Application
  6. 5.2.1 Global Pet Calming Pheromone Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pet Calming Pheromone Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pet Calming Pheromone Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pet Calming Pheromone Sales Value by Application
  10. 5.3.1 Global Pet Calming Pheromone Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pet Calming Pheromone Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pet Calming Pheromone Sales Value Share by Application (2021-2032)
6 Pet Calming Pheromone Regional Sales and Value Analysis
  1. 6.1 Global Pet Calming Pheromone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet Calming Pheromone Sales by Region (2021-2032)
  3. 6.2.1 Global Pet Calming Pheromone Sales by Region: 2021-2026
  4. 6.2.2 Global Pet Calming Pheromone Sales by Region (2027-2032)
  5. 6.3 Global Pet Calming Pheromone Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pet Calming Pheromone Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pet Calming Pheromone Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pet Calming Pheromone Sales Value by Region (2027-2032)
  9. 6.5 Global Pet Calming Pheromone Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pet Calming Pheromone Sales Value (2021-2032)
  12. 6.6.2 North America Pet Calming Pheromone Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pet Calming Pheromone Sales Value (2021-2032)
  15. 6.7.2 Europe Pet Calming Pheromone Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pet Calming Pheromone Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pet Calming Pheromone Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pet Calming Pheromone Sales Value (2021-2032)
  21. 6.9.2 South America Pet Calming Pheromone Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pet Calming Pheromone Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pet Calming Pheromone Sales Value Share by Country, 2025 VS 2032
7 Pet Calming Pheromone Country-level Sales and Value Analysis
  1. 7.1 Global Pet Calming Pheromone Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pet Calming Pheromone Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pet Calming Pheromone Sales by Country (2021-2032)
  4. 7.3.1 Global Pet Calming Pheromone Sales by Country (2021-2026)
  5. 7.3.2 Global Pet Calming Pheromone Sales by Country (2027-2032)
  6. 7.4 Global Pet Calming Pheromone Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pet Calming Pheromone Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pet Calming Pheromone Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pet Calming Pheromone Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pet Calming Pheromone Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pet Calming Pheromone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 FELIWAY (Ceva)
  2. 8.1.1 FELIWAY (Ceva) Company Information
  3. 8.1.2 FELIWAY (Ceva) Business Overview
  4. 8.1.3 FELIWAY (Ceva) Pet Calming Pheromone Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 FELIWAY (Ceva) Pet Calming Pheromone Product Portfolio
  6. 8.1.5 FELIWAY (Ceva) Recent Developments
  7. 8.2 ADAPTIL (Ceva)
  8. 8.2.1 ADAPTIL (Ceva) Company Information
  9. 8.2.2 ADAPTIL (Ceva) Business Overview
  10. 8.2.3 ADAPTIL (Ceva) Pet Calming Pheromone Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 ADAPTIL (Ceva) Pet Calming Pheromone Product Portfolio
  12. 8.2.5 ADAPTIL (Ceva) Recent Developments
  13. 8.3 Comfort Zone (Central Garden & Pet)
  14. 8.3.1 Comfort Zone (Central Garden & Pet) Company Information
  15. 8.3.2 Comfort Zone (Central Garden & Pet) Business Overview
  16. 8.3.3 Comfort Zone (Central Garden & Pet) Pet Calming Pheromone Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Comfort Zone (Central Garden & Pet) Pet Calming Pheromone Product Portfolio
  18. 8.3.5 Comfort Zone (Central Garden & Pet) Recent Developments
  19. 8.4 Sentry (PetIQ)
  20. 8.4.1 Sentry (PetIQ) Company Information
  21. 8.4.2 Sentry (PetIQ) Business Overview
  22. 8.4.3 Sentry (PetIQ) Pet Calming Pheromone Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sentry (PetIQ) Pet Calming Pheromone Product Portfolio
  24. 8.4.5 Sentry (PetIQ) Recent Developments
  25. 8.5 ThunderWorks (Ceva)
  26. 8.5.1 ThunderWorks (Ceva) Company Information
  27. 8.5.2 ThunderWorks (Ceva) Business Overview
  28. 8.5.3 ThunderWorks (Ceva) Pet Calming Pheromone Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 ThunderWorks (Ceva) Pet Calming Pheromone Product Portfolio
  30. 8.5.5 ThunderWorks (Ceva) Recent Developments
  31. 8.6 Nature's Miracle (Spectrum Brands)
  32. 8.6.1 Nature's Miracle (Spectrum Brands) Company Information
  33. 8.6.2 Nature's Miracle (Spectrum Brands) Business Overview
  34. 8.6.3 Nature's Miracle (Spectrum Brands) Pet Calming Pheromone Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Nature's Miracle (Spectrum Brands) Pet Calming Pheromone Product Portfolio
  36. 8.6.5 Nature's Miracle (Spectrum Brands) Recent Developments
  37. 8.7 ZENIDOG (Virbac)
  38. 8.7.1 ZENIDOG (Virbac) Company Information
  39. 8.7.2 ZENIDOG (Virbac) Business Overview
  40. 8.7.3 ZENIDOG (Virbac) Pet Calming Pheromone Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 ZENIDOG (Virbac) Pet Calming Pheromone Product Portfolio
  42. 8.7.5 ZENIDOG (Virbac) Recent Developments
  43. 8.8 Beaphar
  44. 8.8.1 Beaphar Company Information
  45. 8.8.2 Beaphar Business Overview
  46. 8.8.3 Beaphar Pet Calming Pheromone Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Beaphar Pet Calming Pheromone Product Portfolio
  48. 8.8.5 Beaphar Recent Developments
  49. 8.9 Cature
  50. 8.9.1 Cature Company Information
  51. 8.9.2 Cature Business Overview
  52. 8.9.3 Cature Pet Calming Pheromone Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Cature Pet Calming Pheromone Product Portfolio
  54. 8.9.5 Cature Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pet Calming Pheromone Value Chain Analysis
  2. 9.1.1 Pet Calming Pheromone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pet Calming Pheromone Sales Mode & Process
  6. 9.2 Pet Calming Pheromone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pet Calming Pheromone Distributors
  9. 9.2.3 Pet Calming Pheromone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst